Company press releases

Displaying 1 - 44 of 44 results
Released Company Title Industry Topic
19 Dec 2024
18:00 CET 		OXURION French Authorities Approve Oxurion's Strategic Transaction Under Specific Conditions 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Dec 2024
18:00 CET 		OXURION Les autorités françaises approuvent la transaction stratégique d'Oxurion, sous certaines conditions spécifiques 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Dec 2024
18:00 CET 		OXURION Franse autoriteiten keuren de strategische transactie van Oxurion goed onder specifieke voorwaarden 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
12 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
12 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
09 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
09 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
05 Dec 2024
18:00 CET 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
05 Dec 2024
18:00 CET 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
04 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
04 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
02 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
02 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
28 Nov 2024
19:00 CET 		OXURION Oxurion announces that its potential acquisition is subject to foreign investment control 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
28 Nov 2024
19:00 CET 		OXURION Oxurion annonce que son acquisition potentielle est soumise au contrôle des investissements étrangers 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
14 Nov 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Nov 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
05 Nov 2024
10:30 CET 		OXURION Oxurion beëindigt haar privé gerechtelijke reorganisatieprocedure na minnelijke schikkingen 20103010 Biotechnology Legal
05 Nov 2024
10:30 CET 		OXURION Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements 20103010 Biotechnology Legal
05 Nov 2024
10:30 CET 		OXURION Oxurion met fin à sa procédure de réorganisation judiciaire privée à la suite d'accords de règlement à l'amiable 20103010 Biotechnology Legal
29 Oct 2024
22:00 CET 		OXURION Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname 20103010 Biotechnology Other subject
29 Oct 2024
22:00 CET 		OXURION Oxurion NV : Principales évolutions et calendrier concernant l'acquisition potentielle en cours 20103010 Biotechnology Other subject
29 Oct 2024
22:00 CET 		OXURION Oxurion NV: Key developments and timeline for current the potential acquisition 20103010 Biotechnology Other subject
24 Oct 2024
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
24 Oct 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Oct 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Oct 2024
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
10 Oct 2024
18:00 CEST 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
10 Oct 2024
18:00 CEST 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
02 Oct 2024
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
02 Oct 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
30 Sep 2024
18:00 CEST 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
30 Sep 2024
18:00 CEST 		OXURION Oxurion Publishes First Half 2024 Results 20103010 Biotechnology Sales, Income
30 Sep 2024
18:00 CEST 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
30 Sep 2024
18:00 CEST 		OXURION Oxurion publie ses résultats du premier semestre 2024 20103010 Biotechnology Sales, Income
16 Sep 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
16 Sep 2024
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
09 Sep 2024
22:00 CEST 		OXURION Information on the Total Number of Voting Rights (Denominator) following a reverse share split 20103010 Biotechnology Change in Capital
09 Sep 2024
22:00 CEST 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op een aandelenconsolidatie 20103010 Biotechnology Change in Capital
03 Sep 2024
22:10 CEST 		OXURION Oxurion annonce l'Ouverture d'une Procédure de Réorganisation Judiciaire Privée 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
03 Sep 2024
22:10 CEST 		OXURION Oxurion Announces the Opening of a Private Judicial Reorganization Procedure 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
03 Sep 2024
18:20 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Sep 2024
18:00 CEST 		OXURION Oxurion NV announces date of consolidation of shares and last day of trading of current shares 20103010 Biotechnology Change in Capital
03 Sep 2024
18:00 CEST 		OXURION Oxurion NV annonce la date de consolidation des actions et la dernière journée de cotation des actions actuelles 20103010 Biotechnology Change in Capital